Observer-Blinded Dose Escalating, Single Dose to Study Safety and Antimicrobial Efficacy of Gel vs. Placebo

Summary

A Randomized, Observer-Blinded, Vehicle Controlled, Single Dose, Dose Escalating, Single Application Within-patient Bilateral Comparison. The goal is to determine the safety and tolerability of DBI-001 Gel vs. Placebo in Adults with Atopic Dermatitis (AD).

Timeline

Start

2019-05-20

Primary completion

2020-06-30

Completion

2020-06-30

Outcome

Outcome not reported

Stopped: “Covid-19 has shut the clinic indefinitely”

Drugs

Indications